Advertisement
New Zealand markets open in 9 hours 37 minutes
  • NZX 50

    11,804.84
    -111.94 (-0.94%)
     
  • NZD/USD

    0.5888
    -0.0018 (-0.31%)
     
  • ALL ORDS

    7,862.30
    -147.10 (-1.84%)
     
  • OIL

    84.94
    -0.47 (-0.55%)
     
  • GOLD

    2,391.00
    +8.00 (+0.34%)
     

Could Bristol Myers Squibb and Johnson & Johnson Have a Powerful New Blood Thinner on the Way?

Bristol Myers Squibb (NYSE: BMY) and Johnson & Johnson (NYSE: JNJ) compete against each other in the marketplace every day. In this Motley Fool Live video recorded on Nov. 16, 2021, Motley Fool contributors Keith Speights and Brian Orelli discuss the prospects for this experimental drug. Keith Speights: Bristol Myers Squibb and Johnson & Johnson compete head-to-head in the blood thinner market.